EP2609928
Notkun kannabínóíða ásamt arípíprasóli
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
17.12.2008EP published:
17.7.2019EP application number:
13152600.6
EP translation filed:
16.10.2019Grant published:
15.11.2019EPO information:
European Patent Register
Max expiry date:
16.12.2028Expiry date:
16.12.2024
Title:
Use of cannabinoids in combination with Aripiprazole
Timeline
Today
17.12.2008EP application
17.7.2019EP Publication
16.10.2019Translation submitted
15.11.2019Registration published
16.12.2024Expires
Owner
Name:
GW Pharma LimitedAddress:
Sovereign House, Histon Cambridge CB24 9BZ, GB
Inventor
Name:
Kikuchi, TetsuroAddress:
Osaka,, JP
Name:
Maeda, KenjiAddress:
Osaka,, JP
Name:
Guy, GeoffreyAddress:
SALISBURY, SP4 0JR, GB
Name:
Robson, PhilipAddress:
SALISBURY, SP4 0JQ, GB
Name:
Stott, ColinAddress:
SALISBURY, SP4 0JQ, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
0800390Date:
4.1.2008Country:
GB
Classification
Categories:
A61K 36/185, A61K 31/352, A61K 31/35, A61K 31/05, A61K 45/06, A61P 25/18, A61P 25/22
Annual fees
Number
Paid
Expires
Payer
Number: 12
Paid: 3.12.2019
Expires: 16.12.2020
Payer: PATICE
Number: 13
Paid: 14.12.2020
Expires: 16.12.2021
Payer: Patice ehf.
Number: 14
Paid: 16.12.2021
Expires: 16.12.2022
Payer: Patice ehf.
Number: 15
Paid: 22.12.2022
Expires: 16.12.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 15.12.2023
Expires: 16.12.2024
Payer: Árnason Faktor ehf.